Continuing Education

Circulation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/14/1″>Volume 14, Issue 1</a>, January 1, 2021. Source link

Keith E. Kocher Keith Kocher, MD, MPH, University of Michigan, NCRC Bldg 14, 2800 Plymouth Rd, Ann Arbor, MI 48109-2800,

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link

Background: Use of angiotensin-converting enzyme inhibitors (ACEIs) was associated with increased risk of lung cancer in a cohort study from

Background: Cardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (CVD) risk based on the pooled cohort equations to guide

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BackgroundData from administrative claims may provide an efficient alternative for end point

Circulation: Heart Failure, Ahead of Print. Source link

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BackgroundRecent evidence from randomized controlled trials has raised concerns about the long-term

Brahmajee K. Nallamothu https://orcid.org/0000-0003-4331-6649 Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan, MI; Michigan Integrated Center for

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BackgroundWide variation exists for hospital admission rates for the evaluation of possible